Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.

Autor: Tonsing-Carter E; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Hernandez KM; Center for Research Informatics, The University of Chicago, Chicago, IL, 60637, USA.; Department of Pediatrics, The University of Chicago, Chicago, IL, 60637, USA., Kim CR; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Harkless RV; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Oh A; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Bowie KR; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., West-Szymanski DC; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Betancourt-Ponce MA; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Green BD; Ben May Department for Cancer Research, The University of Chicago, 900 E 57th St, Chicago, IL, 60637, USA., Lastra RR; Department of Pathology, The University of Chicago, Chicago, IL, 60637, USA., Fleming GF; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA., Chandarlapaty S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Conzen SD; Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA. sdconzen@uchicago.edu.; Ben May Department for Cancer Research, The University of Chicago, 900 E 57th St, Chicago, IL, 60637, USA. sdconzen@uchicago.edu.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2019 Jul 24; Vol. 21 (1), pp. 82. Date of Electronic Publication: 2019 Jul 24.